256 related articles for article (PubMed ID: 21737611)
1. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
[TBL] [Abstract][Full Text] [Related]
2. EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.
Johnson C; Segovia B; Kandpal RP
Cancer Genomics Proteomics; 2016 09-10; 13(5):359-68. PubMed ID: 27566654
[TBL] [Abstract][Full Text] [Related]
3. EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
Husa AM; Magić Ž; Larsson M; Fornander T; Pérez-Tenorio G
Oncotarget; 2016 Apr; 7(16):21362-80. PubMed ID: 26870995
[TBL] [Abstract][Full Text] [Related]
4. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.
Kandpal RP
Cancer Genomics Proteomics; 2010; 7(5):253-60. PubMed ID: 20952760
[TBL] [Abstract][Full Text] [Related]
6. Modulation of liver-intestine cadherin (Cadherin 17) expression, ERK phosphorylation and WNT signaling in EPHB6 receptor-expressing MDA-MB-231 cells.
Bhushan L; Tavitian N; Dey D; Tumur Z; Parsa C; Kandpal RP
Cancer Genomics Proteomics; 2014; 11(5):239-49. PubMed ID: 25331796
[TBL] [Abstract][Full Text] [Related]
7. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.
Fox BP; Kandpal RP
Biochem Biophys Res Commun; 2004 Jun; 318(4):882-92. PubMed ID: 15147954
[TBL] [Abstract][Full Text] [Related]
8. Dancing with the dead: Eph receptors and their kinase-null partners.
Truitt L; Freywald A
Biochem Cell Biol; 2011 Apr; 89(2):115-29. PubMed ID: 21455264
[TBL] [Abstract][Full Text] [Related]
9. Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction.
Allonby O; El Zawily AM; Freywald T; Mousseau DD; Chlan J; Anderson D; Benmerah A; Sidhu V; Babu M; DeCoteau J; Freywald A
Cell Signal; 2014 Dec; 26(12):2645-57. PubMed ID: 25152371
[TBL] [Abstract][Full Text] [Related]
10. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
[TBL] [Abstract][Full Text] [Related]
11. The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs.
Liang LY; Roy M; Horne CR; Sandow JJ; Surudoi M; Dagley LF; Young SN; Dite T; Babon JJ; Janes PW; Patel O; Murphy JM; Lucet IS
Biochem J; 2021 Sep; 478(17):3351-3371. PubMed ID: 34431498
[TBL] [Abstract][Full Text] [Related]
12. Structure of the EphB6 receptor ectodomain.
Mason EO; Goldgur Y; Robev D; Freywald A; Nikolov DB; Himanen JP
PLoS One; 2021; 16(3):e0247335. PubMed ID: 33770085
[TBL] [Abstract][Full Text] [Related]
13. Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor.
Liu J; Xu B; Xu G; Zhang X; Yang X; Wang J
Cancer Biomark; 2017 Jul; 19(3):241-248. PubMed ID: 28453458
[TBL] [Abstract][Full Text] [Related]
14. EphB6 promotes anoikis by modulating EphA2 signaling.
Akada M; Harada K; Negishi M; Katoh H
Cell Signal; 2014 Dec; 26(12):2879-84. PubMed ID: 25239188
[TBL] [Abstract][Full Text] [Related]
15. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
Zadeh T; Lucero M; Kandpal RP
Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
[TBL] [Abstract][Full Text] [Related]
16. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
17. Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells.
Chukkapalli S; Amessou M; Dilly AK; Dekhil H; Zhao J; Liu Q; Bejna A; Thomas RD; Bandyopadhyay S; Bismar TA; Neill D; Azoulay L; Batist G; Kandouz M
Exp Cell Res; 2014 Jan; 320(2):233-46. PubMed ID: 24211352
[TBL] [Abstract][Full Text] [Related]
18. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R
J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095
[TBL] [Abstract][Full Text] [Related]
19. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.
Brantley-Sieders DM; Fang WB; Hicks DJ; Zhuang G; Shyr Y; Chen J
FASEB J; 2005 Nov; 19(13):1884-6. PubMed ID: 16166198
[TBL] [Abstract][Full Text] [Related]
20. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
Fox BP; Kandpal RP
Oncogene; 2009 Apr; 28(14):1706-13. PubMed ID: 19234485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
